Welcome to SBS 2011 - SLAS

Gaylord Palms Resort and Convention Center | March 27–31, 2011 | Orlando, Florida, USA
9:00 am – 12:00 pm Osceola C
Track II » Session 3: Molecular Discovery in
Non-Traditional, Neglected and Rare Diseases
Session Chair: Bob Hertzberg, GlaxoSmithKline
9:00 – 9:30 am Page 58
Plenary: Opening the Doors and Giving Back: GSK’s Strategy to Deliver
Medicines for Diseases of the Developing Worlds; Bob Hertzberg,
GlaxoSmithKline
High-Throughput Screening to Identify Inhibitors of the Respiratory
9:30 – 10:00 am Page 58 Chain of Mycobacterium Tuberculosis; Khisimuzi Mdluli, Global Alliance
for TB Drug Development
10:30 – 11:00 am Page 59
The Development of RNA-Modulating Therapies; Judith C.T. van Deutekom,
Prosensa Therapeutics BV, Leiden
11:00 – 11:30 am Page 59
Humanitarian and Commercial Cloud-Based Collaborative Drug Discovery;
Kellan Gregory, Collaborative Drug Discovery (CDD), Inc.
Potent and Selective Inhibitors of the Plasmodium Falciparum M18
11:30 am – 12:00 pm Page 59
Aspartyl Aminopeptidase (AAP) of Human Malaria Identified via a QFRET
uHTS Campaign; Virneliz Fernandez Vega, The Scripps Research Institute,
Scripps Florida
Track III » Session 3: Applications in Consumer Products,
9:00 am – 12:00 pm Osceola B Cosmetics, Nutraceuticals and Agriculture
Session Chair: Sabrina Corazza, Axxam SpA
9:00 – 9:30 am Page 61
Plenary: New Frontiers for HTS Application: How and Why; Sabrina Corazza,
Axxam SpA
9:30 – 10:00 am Page 61
Receptor Mediated Discovery of Novel Taste Modulators; Jay Slack,
Givaudan Flavors Corp.
10:30 – 11:00 am Page 61
Insecticidal Compounds “Well” Spotted: Screening Live Bugs in a
High-Throughput System; Juergen Langewald, BASF
11:00 – 11:30 am Page 62 Needs of the Food and Beverage Industries; Anthony J. Clark, PepsiCo
11:30 am – 12:00 pm Page 62
Deorphanization and Characterization of Human Odorant Receptors
in Heterologous Cells; Pierre Chatelein, TecnoScent
Track I » Session 4: Innovations in Label-Free, Multiplexed
2:00 – 4:30 pm Osceola A and High-Content Assays
Session Chair: James Inglese, NIH Chemical Genomics Center
Plenary: Quantitative High-Throughput Screening of Phenotypic Assays
2:00 – 2:30 pm Page 64 Enabled by Laser-Scanning-Coupled Microscopy; James Inglese, NIH
Chemical Genomics Center
2:30 – 3:00 pm Page 64
Kinetic Image Cytometry: Toxicity HCS in Human Cardiomyocytes
for Early Drug Discovery; Jeffrey Price, Sanford Burnham
3:00 – 3:30 pm Page 64
Binding Assays in Biological Liquids Using Microscale Thermophoresis;
Stefan Duhr, NanoTemper Technologies
3:30 – 4:00 pm Page 65
Use of Label-Free Technology to Monitor GPCR Desensitization;
Patricia McDonald, Scripps Research Institute
4:00 – 4:30 pm Page 65
Enabling Lead Discovery at Epigenetics Targets With RapidFireTM Mass
Spectrometry; Melanie Leveridge, GlaxoSmithKline
SLAS.org/events/sbs11 | 33